Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 23 |
| Active Pipeline (Recruiting Now) | 5 (2) |
| Completed vs Stopped Early | 16 / 1 (4.3%) |
| Median Closed Actual Enrollment | 473 participants |
| Physical Hospital Site Disclosure | 94.1% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 12 (11 since 2018) |
Explore interactive annual charts and M&A subsidiary rollups in the Celltrion Interactive Dossier, benchmark peers in Immunology, Rheumatology, and Dermatology, or review the Healthcare Price & Patent Cliff Crosswalk.